Boston Scientific accounts are for healthcare professionals only.
OPAL HDx™ Mapping System
Configure or select a product to continue to order
- Overview
- Clinical data
- Technical specifications
- Ordering information
- Training
- Service plan
- Resources
- OPTIMAP™ Integration
How it works
The OPAL HDx™ Mapping System is optimized for FARAPULSE(TM) PFA and integrates with a full suite of catheters and software modules, combining real-time validation, and advanced mapping to support workflows from posterior vein isolation (PVI) to complex arrhythmias.
The mapping solution optimized for FARAPULSE™ PFA
The FARAVIEW™ Software Module provides the optimal experience for FARAPULSE™ PFA procedures, unlocking workflow simplicity and procedural confidence. FARAVIEW provides procedural feedback to enable physicians to clearly see catheter position, catheter contact, and estimated PFA field coverage before and after energy is delivered.
Advanced mapping tools
The OPAL HDx Mapping System integrates high-density mapping, intelligent annotation, and advanced electrogram analysis algorithms to localize even the most complex arrhythmias with precision and confidence.
Future mapping innovations
Boston Scientific is continuously advancing the OPAL HDx system through frequent, innovative updates that expand capability and performance. The OPAL HDx system will be furthering capabilities through integration with OPTIMAP™, introducing electrographic flow mapping to support the identification of nonpulmonary vein sources of atrial fibrillation.
The OPTIMAP™ System is 510(k) cleared and is not yet available for sale in the United States.
Clinical data
DISRUPT-AF real-world registry1
Safe, efficient single-catheter map and ablate workflow with the FARAWAVE™ NAV Pulsed Field Ablation (PFA) Catheter, visualized with FARAVIEW™ Software Module on the OPAL HDx™ Mapping System. The DISRUPT-AF real-world registry (n=477) showed a 0.2% catheter-related complication event rate, predictable procedures and an average fluoroscopy time of 3.8 minutes.
NAVIGATE-PF trial2
The NAVIGATE-PF clinical trial was a multi-center, first-in-human feasibility study that assessed the acute and chronic accuracy of FIELDTAG™ Technology on the FARAVIEW™ Software Module in visualizing pulsed field energy delivery by the FARAWAVE™ NAV catheter. The study included two phases:
Phase I (acute assessment):
Phase 1 included 30 patients that underwent PV isolation, with 30% also receiving posterior wall ablation.
PFA markers were placed during PFA application and high-quality, post-ablation HD maps with INTELLAMAP ORION™ Mapping Catheter were completed in 15 pts. PFA markers were overlaid on the HD map and contours were drawn at the outer border of the low voltage areas (defined as ≤0.5mV) where at least 2 overlapping PFA markers were dropped.
Phase II (chronic assessment):
Included 20 patients at 1 center to evaluate chronic lesion durability and alignment between acute PFA tag locations and chronic low voltage borders.
NAVIGATE-PF3: 60 day remap
60-day remapping after FARAWAVE NAV PFA Catheter ablation showed 95% (63/66) PV durability and 86% (12/14) PW durability.
FLOW-AF4
The FLOW-AF study provided the first randomized evidence for EGF mapping in AF treatment. The study demonstrated a 51% improvement (on an absolute basis) in Freedom from AF at 1 year with pulmonary vein isolation (PVI) + EGF-guided mapping and ablation versus PVI alone.
OPAL HDx™ Mapping System
| Feature | Specifications |
| Signal Station | Dimensions (W x D x H): 41.0 x 38.9 x 26.2 (centimeter) 16.2 x 15.3 x 10.3 (inches) |
| Workstation PC | Dimensions Z-series (W x D x H): 17.1 x 47.3 x 44.3 (centimeter) 6.8 x 18.7 x 17.5 (inches) |
| Monitor Display size: 24" | Dimensions (W xD x H): 56.2 x 6.1 x 36.8 (centimeter) 22.1 x 2.4 x 14.5 (inches) |
| Localization Generator | Dimensions (W x D x H): 45.0 x 55.4 x 7.0 (centimeter) 17.8 x 21.9 x 2.8 (inches) |
| System Cart | Dimensions (W x D x H) without monitor: Dimensions (W x D x H) with monitor: |
| Workstation PC Cart Holds the Workstation, monitor, keyboard, and mouse | Dimensions (W x D x H) with monitor: 71.2 x 57.2 x 147.4 (centimeter) 28.0 x 22.5 x 58.0 (inches) |
Ordering information
| UPN Description | UPN# | GTIN# |
| OPAL HDx Mapping Sys Install Bundle 2 EN | M004OPLINSTALL2EN0 | 00191506055370 |
| OPAL HDx Signal Station 2 | M004OPAL10200 | 00191506055325 |
| OPAL HDx WORKSTATION PC | M004OPAL40100 | 00191506055301 |
Reimbursement information
Locate procedural coding and reimbursement information for inpatient, outpatient, office, and ASC settings on our reimbursement page. You’ll also find coding and payment guides for cardiac rhythm management and electrophysiology.
Customer support plans
The ExpertCare Program includes tailored plans offering 24-hour technical assistance and expert collaboration in support of Boston Scientific electrophysiology systems.
Online education
Online medical training and education courses
The EDUCARE online platform makes health care education and training more relevant, more comprehensive, more personal, and more accessible. Register to access a library of procedural videos, case studies, training resources, and events.
The ExpertCare Program is designed to provide you with continued confidence in Boston Scientific products, customer support, and technical services. Technical support is available 24 hours a day. Our service team has the expertise that comes from years of collaboration with our customers to better support your commitment to patient care.
Boston Scientific ExpertCare service plans will provide you extraordinary value in three key areas.
Cost Control - There is nothing worse than an unexpected financial surprise. A prepaid service agreement will eliminate variable maintenance and repairs costs.
Uptime - Time is money and with a prepaid service agreement, you will automatically be in front of the line. Our uptime guarantee is a commitment to delivering the fastest onsite service to systems under an agreement.
Convenience - Prepaid service agreements can eliminate the administrative hassles of purchase orders and associated delays that can slow down the process.
Brochure
Introducing the OPTIMAP™ System
Boston Scientific acquired the OPTIMAP™ System, an advanced diagnostic mapping system that fundamentally changes how physicians visualize and understand the mechanisms of atrial fibrillation (AF).
Powered by a proprietary electrographic flow (EGF) algorithm, OPTIMAP identifies sources: possible triggers or drivers of AF. By pinpointing areas of repeated divergent flow, OPTIMAP locates potential sources that may sustain the arrhythmia and otherwise go undetected.
Traditional ablation strategies often rely on anatomic approaches that may not address the unique arrhythmia mechanisms driving each patient’s AF. OPTIMAP identifies patient-specific sources, enabling physicians to tailor treatment to each individual's AF mechanisms.
OPTIMAP provides reproducible and intuitive outputs. The EGF mapping approach helps physicians focus in on the sources most likely to sustain AF, enabling more precise ablation while potentially minimizing unnecessary ablation.
Future integration with OPAL HDx
The OPTIMAP system is 510(k) cleared and Boston Scientific is advancing clinical research to further characterize and validate the technology before commercialization. OPTIMAP will integrate with the OPAL HDx mapping system, further strengthening Boston Scientific’s integrated mapping and ablation portfolio to support comprehensive AF treatment.
Clinical evidence
Early clinical data suggest that EGF mapping can identify extra-pulmonary vein sources for ablation, which can improve patient outcomes. Ongoing studies continue to expand the evidence base and refine how EGF mapping may shape patient-specific treatment approaches.
Key clinical studies:
- The FLOW-AF study provided the first randomized evidence for EGF mapping in AF treatment. The study demonstrated a 51% improvement (on an absolute basis) in Freedom from AF at 1 year with pulmonary vein isolation (PVI) + EGF-guided mapping and ablation versus PVI alone.
Explore the FLOW-AF Study Results to learn more.
- The RESOLVE-AF study builds on FLOW-AF by evaluating an updated OPTIMAP algorithm in a larger, more diverse patient population.
- The OPTIMIZE randomized controlled trial pairs OPTIMAP EGF mapping with the FARAPULSE PFA Platform to investigate the effectiveness of EGF mapping when paired with the Boston Scientific EP portfolio.
The OPTIMAP™ System is 510(k) cleared and is not yet available for sale in the United States.
Related products
References:
1. Nair, D., et al. (2026) Clinical experience with map-and-ablate workflows enabled by the second-generation catheter: findings from the DISRUPT-AF Registry. Presented at AF Symposium 2026.
2. Reddy, V. et al. (2025). Visualization and chronic assessment of electrical field tags for pulsed field ablation of pulmonary veins with the second-generation pentaspline catheter. Presented at HRS 2025.
3. Reddy, V. Y., et al. (2026). Chronic lesion prediction of pulsed field ablation using dynamic shape visualization and tags with the second-generation pentaspline catheter. Presented at AF Symposium 2026.
4. Reddy, V. Y. (2024). A Randomized Trial of Electrographic Flow-Guided Redo Ablation for Nonparoxysmal Atrial Fibrillation (FLOW-AF). JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2024.03.040